Literature DB >> 7398396

Melphalan-induced pulmonary interstitial fibrosis.

G Goucher, V Rowland, J Hawkins.   

Abstract

Diffuse interstitial fibrosis developed in a patient receiving therapy with melphalan for multiple myeloma. With cessation of the administration of the alkylating agent and corticosteroid, we describe progressive radiographic improvement in this patient, accompanied by persistent severe impairment in gas exchange.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7398396     DOI: 10.1378/chest.77.6.805

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  2 in total

Review 1.  Interstitial lung disease in lung cancer: separating disease progression from treatment effects.

Authors:  Sarah Danson; Fiona Blackhall; Paul Hulse; Malcolm Ranson
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

2.  Bortezomib-induced bronchiolitis obliterans organizing pneumonia.

Authors:  E Vandeix; F Favard; N Pichon; M Delage-Corre; B Melloni; M Clavel
Journal:  Case Rep Pulmonol       Date:  2012-10-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.